HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
First Patient in Erectile Dysfunction Feasibility Study with Sirolimus Drug-Eluting Balloon
The aim of the study is to assess the feasibility and safety of angioplasty with a sirolimus-eluting balloon in patients with ED and distal internal pudendal and/or penile artery stenotic disease, using Plain Old Balloon (POB) angioplasty as a comparator.
New Study Shows Advanced Treatment (AT) for Management of LEDUs Among Medicare Beneficiaries is Associated with Significant Reductions in Major & Minor Amputation, Emergency...
“The data derived from this study are important for a number of reasons,” noted Dr. David G. Armstrong, Professor of Surgery and Director of the Southwestern Academic Limb Salvage Alliance (SALSA) at the Keck School of Medicine of the University of Southern California. Read more.
SELUTION SLR Sirolimus Drug Eluting Balloon Clinical Trial Completed
The 12-month data from PRESTIGE was presented at LINC 2021 in January, showing sustained benefits up to one year. 18-month data is to be presented at VIVA in October this year, where it is anticipated that these benefits will be further sustained.
Endoform Natural Real-World Data Study Is Released: Available On Line
The findings have been published this week in a study titled “Retrospective Real World Comparative Effectiveness of Ovine Forestomach Matrix and Collagen/ORC in the Management of Diabetic Foot Ulcers” published in the ‘International Wound Journal.’
Synedgen RCT Underway: Test Safety of SynPure & Catasyn
Synedgen: RCT Underway to Test Safety of SynPure and Catasyn
Synedgen, a biotechnology company using glycopolymer chemistry to develop therapeutics that enhance and control signaling...
Positive Aerin Medical AERWAY Study Results Published Showing Effectiveness of VivAer® For Nasal Obstruction Patients with Nasal Valve Collapse
Study adds to a growing body of clinical evidence supporting the safety and efficacy of VivAer, a non-invasive, temperature-controlled radiofrequency device.
HRS Scientific Sessions: Boston Scientific LBCT
During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.
The LimFlow System Found to be Cost-Effective, According to the Newest Study Published in the Journal of Critical Limb Ischemia
Percutaneous Deep Vein Arterialization (pDVA) with the LimFlow System offers a cost-effective and high-value alternative to traditional therapies or amputation in a new study, published June 2021.
FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial
SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.